541 related articles for article (PubMed ID: 16403804)
1. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.
Melcon G; Kozlov S; Cutler DA; Sullivan T; Hernandez L; Zhao P; Mitchell S; Nader G; Bakay M; Rottman JN; Hoffman EP; Stewart CL
Hum Mol Genet; 2006 Feb; 15(4):637-51. PubMed ID: 16403804
[TBL] [Abstract][Full Text] [Related]
2. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
[TBL] [Abstract][Full Text] [Related]
3. Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes.
Holaska JM; Rais-Bahrami S; Wilson KL
Hum Mol Genet; 2006 Dec; 15(23):3459-72. PubMed ID: 17067998
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of Emery-Dreifuss muscular dystrophy.
Wheeler MA; Ellis JA
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1354-8. PubMed ID: 19021555
[TBL] [Abstract][Full Text] [Related]
5. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.
Frock RL; Kudlow BA; Evans AM; Jameson SA; Hauschka SD; Kennedy BK
Genes Dev; 2006 Feb; 20(4):486-500. PubMed ID: 16481476
[TBL] [Abstract][Full Text] [Related]
6. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.
Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G
J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034
[TBL] [Abstract][Full Text] [Related]
7. EDMD-Causing Emerin Mutant Myogenic Progenitors Exhibit Impaired Differentiation Using Similar Mechanisms.
Iyer A; Holaska JM
Cells; 2020 Jun; 9(6):. PubMed ID: 32549231
[TBL] [Abstract][Full Text] [Related]
8. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.
Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM
Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684
[TBL] [Abstract][Full Text] [Related]
9. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
[TBL] [Abstract][Full Text] [Related]
10. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies.
Maraldi NM; Lattanzi G; Capanni C; Columbaro M; Merlini L; Mattioli E; Sabatelli P; Squarzoni S; Manzoli FA
Eur J Histochem; 2006; 50(1):1-8. PubMed ID: 16584978
[TBL] [Abstract][Full Text] [Related]
11. Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle.
Zhang Q; Ragnauth CD; Skepper JN; Worth NF; Warren DT; Roberts RG; Weissberg PL; Ellis JA; Shanahan CM
J Cell Sci; 2005 Feb; 118(Pt 4):673-87. PubMed ID: 15671068
[TBL] [Abstract][Full Text] [Related]
12. Identification of tyrosine-phosphorylation sites in the nuclear membrane protein emerin.
Schlosser A; Amanchy R; Otto H
FEBS J; 2006 Jul; 273(14):3204-15. PubMed ID: 16857009
[TBL] [Abstract][Full Text] [Related]
13. Does satellite cell dysfunction contribute to disease progression in Emery-Dreifuss muscular dystrophy?
Gnocchi VF; Ellis JA; Zammit PS
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1344-9. PubMed ID: 19021553
[TBL] [Abstract][Full Text] [Related]
14. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy.
Nagano A; Koga R; Ogawa M; Kurano Y; Kawada J; Okada R; Hayashi YK; Tsukahara T; Arahata K
Nat Genet; 1996 Mar; 12(3):254-9. PubMed ID: 8589715
[TBL] [Abstract][Full Text] [Related]
15. Nuclear envelope proteins and neuromuscular diseases.
Ostlund C; Worman HJ
Muscle Nerve; 2003 Apr; 27(4):393-406. PubMed ID: 12661041
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
17. CDNA microarray analysis of gene expression in fibroblasts of patients with X-linked Emery-Dreifuss muscular dystrophy.
Tsukahara T; Tsujino S; Arahata K
Muscle Nerve; 2002 Jun; 25(6):898-901. PubMed ID: 12115980
[TBL] [Abstract][Full Text] [Related]
18. Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy.
Haraguchi T; Holaska JM; Yamane M; Koujin T; Hashiguchi N; Mori C; Wilson KL; Hiraoka Y
Eur J Biochem; 2004 Mar; 271(5):1035-45. PubMed ID: 15009215
[TBL] [Abstract][Full Text] [Related]
19. How does a g993t mutation in the emerin gene cause Emery-Dreifuss muscular dystrophy?
Holt I; Clements L; Manilal S; Morris GE
Biochem Biophys Res Commun; 2001 Oct; 287(5):1129-33. PubMed ID: 11587540
[TBL] [Abstract][Full Text] [Related]
20. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.
Ishibashi J; Perry RL; Asakura A; Rudnicki MA
J Cell Biol; 2005 Nov; 171(3):471-82. PubMed ID: 16275751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
